COMMUNIQUÉ DE PRESSE publié le 18/01/2024 à 13:00, il y a 1 année 2 mois Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer Envision Pharma Group appoints Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team. With her extensive experience in the life sciences industry, Carolyn is set to play a crucial role in securing and retaining top talent to support Envision's growth. Her strategic vision aligns seamlessly with the company's priorities, and her exceptional leadership experience will be integral to advancing Envision's strategic goals. Envision Pharma Group Talent Acquisition Life Sciences Industry Carolyn Bartholdson Chief People Officer
COMMUNIQUÉ DE PRESSE publié le 16/01/2024 à 13:00, il y a 1 année 2 mois Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) to lead the organization's IMC division of experts in medical strategy, medical communications, publications planning and delivery, and patient engagement, delivering smarter, faster outcomes for life sciences clients. With a wealth of experience in the global life sciences industry, Alice brings strategic expertise, knowledge, and insight to drive the company's vision forward and meet client needs. She joins from IPG Health, where she served as EVP, Managing Director, Client Solutions, APAC, and played a pivotal role in business growth and operational excellence. Her commitment to best practices and standards in medical communications is evident in her various leadership roles. Envision Pharma Group, founded in 2001, is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies. Learn more at www.envisionpharmagroup.com. Envision Pharma Group Alice Choi Medical Communications Life Sciences Clients Global Technology-enabled Strategic Solutions
COMMUNIQUÉ DE PRESSE publié le 15/11/2023 à 13:00, il y a 1 année 4 mois Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
COMMUNIQUÉ DE PRESSE publié le 15/06/2023 à 13:00, il y a 1 année 9 mois OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
COMMUNIQUÉ DE PRESSE publié le 09/05/2023 à 13:00, il y a 1 année 10 mois Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
COMMUNIQUÉ DE PRESSE publié le 04/05/2023 à 13:00, il y a 1 année 10 mois Envision Pharma Group Appoints Healthcare Industry Expert and Experienced Leader Dr. Jennifer Costello, PharmD, BCPS, CMPP, as Chief Medical Officer
COMMUNIQUÉ DE PRESSE publié le 03/05/2023 à 15:05, il y a 1 année 10 mois Envision Pharma Group Appoints Mike Glover to Senior Vice President, Payer and HTA Solutions to Drive Acceleration and Expansion in Value & Access and Data Analytics
COMMUNIQUÉ DE PRESSE publié le 01/05/2023 à 13:00, il y a 1 année 11 mois Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights
COMMUNIQUÉ DE PRESSE publié le 30/03/2023 à 13:00, il y a 2 années Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
COMMUNIQUÉ DE PRESSE publié le 29/03/2023 à 17:45, il y a 2 années Envision Pharma Group Appoints Life Science Industry Expert James Streeter as New President of Technology, CTO
Publié le 02/04/2025 à 16:18, il y a 56 minutes LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/03/2025
Publié le 02/04/2025 à 14:36, il y a 2 heures 38 minutes Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Publié le 02/04/2025 à 14:13, il y a 3 heures 2 minutes Mars 2025 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Publié le 02/04/2025 à 09:33, il y a 7 heures 42 minutes ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 31 décembre 2023
Publié le 01/04/2025 à 17:45, il y a 23 heures 30 minutes Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Publié le 02/04/2025 à 15:00, il y a 2 heures 15 minutes Doubleview Gold Corp 2025 Exploration Program
Publié le 02/04/2025 à 14:00, il y a 3 heures 15 minutes Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Publié le 02/04/2025 à 14:00, il y a 3 heures 15 minutes Avant Technologies Partner, Ainnova, to Sponsor and Present at 2025 Healthcare Innovation Summit in Mexico City
Publié le 02/04/2025 à 13:30, il y a 3 heures 45 minutes The Fresh Factory Completes US$3 Million Non-Brokered Private Placement
Publié le 02/04/2025 à 16:20, il y a 55 minutes Décision sur l'ordonnance CO2: le Conseil fédéral scelle une surréglementation de l'industrie automobile nuisible à l'économie
Publié le 02/04/2025 à 16:00, il y a 1 heure 15 minutes Genel Energy PLC: 2025 Awards - Notification of Transactions by Persons Discharging Managerial Responsibilities (‘PDMRs’)
Publié le 02/04/2025 à 15:55, il y a 1 heure 20 minutes OCIM devient propriétaire de deux unités de production d'or situées au Pérou
Publié le 02/04/2025 à 15:54, il y a 1 heure 21 minutes General Meeting of mobilezone holding ltd approves a dividend of CHF 0.90 (previous year: CHF 0.90)